92685 ⎘
Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one amino group bound to the carbon skeleton, e.g. lysine
ARTEMISINIC ACID DERIVATIVE, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF
#2PROCESS FOR MAKING SELADELPAR
#3COMPOUND OR SALT THEREOF, LIPID COMPOSITION, PHARMACEUTICAL COMPOSITION, AND DELIVERY CARRIER
#4NOVEL AMINO ACID DERIVATIVES
#5UNNATURAL AMINO ACID AND USE THEREOF, RECOMBINANT PROTEIN CONTAINING SAME AND RECOMBINANT PROTEIN CONJUGATE
#6AMINO ACID COMPOSITIONS
#7AMINO ACID COMPOSITIONS
#8AMINO ACID COMPOSITIONS
#9AMINO ACID COMPOSITIONS
#10AMINO ACID COMPOSITIONS
#11AMINO ACID COMPOSITIONS
#12AMINO ACID COMPOSITIONS
#13COMPOUND AS MANUFACTURING INTERMEDIATE OF AMINOLIPID OR SALT THEREOF AND METHOD FOR MANUFACTURING AMINOLIPID COMPOUND USING THE COMPOUND
#14SUBSTITUTED (1,2,3,4-TETRAHYDROCYCLOPENTA[b]INDOL-3-YL)ACETIC ACID DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS
#15Improved synthesis of lysine acetylsalicylate - Glycine particles
#16CANNABIDIOL DERIVATIVE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF
#17NOVEL IONIZABLE LIPIDS AND LIPID NANOPARTICLES AND METHODS OF USING THE SAME
#18L-LYSINE SALT OF 4-CHLORO-5-[4-(2,6-DICHLOROPHENYL)SULFONYLPIPERAZIN-1-YL]-1-BENZOFURAN-2-CARBOXYLIC ACID AND VARIOUS FORMS THEREOF
#19AROMATIC-CATIONIC PEPTIDES AND USES OF SAME
#20EP4 ANTAGONIST COMPOUND AS WELL AS SALT, POLYMORPH AND USE THEREOF
#21CATIONIC LIPID, LIPOSOME CONTAINING CATIONIC LIPID, AND NUCLEIC-ACID PHARMACEUTICAL COMPOSITION CONTAINING LIPOSOME AND FORMULATION AND APPLICATION THEREOF
#22NITROGEN-CONTAINING CATIONIC LIPID AND APPLICATION THEREOF
#23SOLUBLE CHELATOR FOR TARGETING RECOMBINANT PROTEINS
#24COMPOUNDS FOR THE TREATMENT OF DISORDERS AND SALTS AND POLYMORPHS THEREOF
#25COMPOUND OR SALT THEREOF, LIPID PARTICLES, AND PHARMACEUTICAL COMPOSITION
#26CO-CRYSTAL OF KETOPROFEN, LYSINE AND GABAPENTIN, PHARMACEUTICAL COMPOSITIONS AND THEIR MEDICAL USE
#27Quaternary ammonium salt for use as a cationic surfactant
#28SUBSTITUTED (1,2,3,4-TETRAHYDROCYCLOPENTA[b]INDOL-3-YL)ACETIC ACID DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS
#29NOVEL ANALOGS OF PTEROSTILBENE AMINO ACID BEARING CARBONATES FOR TREATING A NON-ALCOHOLIC FATTY LIVER DISEASE AND NONALCOHOLIC STEATOHEPATITIS
#30Amino Acid Composition and Method for Catalytic Synthesis of Amino Acid by Means of Energy Radiation
#31AMINO ACID-, PEPTIDE- AND POLYPEPTIDE-LIPIDS, ISOMERS, COMPOSITIONS, AND USES THEREOF
#32DNP and DNP Prodrug Treatment of Neuromuscular, Neurodegenerative, Autoimmune, Developmental, Traumatic Brain Injury, Concussion, Dry Eye Disease, Hearing Loss and/or Metabolic Diseases
#33NITRILOTRIACETIC ACID-CONTAINING LIPIDOID NANOPARTICLES
#343-(5-CHLORO-2-OXOBENZO[D]OXAZOL-3(2H)-YL) PROPANOIC ACID DERIVATIVES AS KMO INHIBITORS
#35DIBENZYLAMINES AS AMINO ACID TRANSPORT INHIBITORS
#36CARBON QUANTUM DOT, A COMPOSITION THEREOF AND A METHOD FOR TREATING INFECTION BY USING SAME
#37L-ORNITHINE PHENYL ACETATE AND METHODS OF MAKING THEREOF
#38APOE4-TARGETED THERAPUTICS THAT INCREASE SIRT1
#39Compositions and methods relating to salts of specialized pro-resolving mediators
#40IONIZABLE AMINE LIPIDS
#41COMPOSITIONS AND METHODS FOR THE TREATMENT OF INFLAMMATORY SKIN DISEASES AND CANCER
#42CRYSTAL OF AMINO ACID SALT OF 3-HYDROXYISOVALERIC ACID AND PRODUCTION METHOD THEREOF
#43Method for producing amino acid aminoalkyl ester or inorganic acid salt thereof
#44Compounds and methods for the treatment of neurodegenerative diseases
#45PEPTIDE NUCLEIC ACID (PNA) MONOMERS WITH AN ORTHOGONALLY PROTECTED ESTER MOIETY AND NOVEL INTERMEDIATES AND METHODS RELATED THERETO
#46Compositions and methods relating to salts of specialized pro-resolving mediators
#47Aromatic-cationic peptides and uses of same
#48SUBSTITUTED (1,2,3,4-TETRAHYDROCYCLOPENTA[b]INDOL-3-YL)ACETIC ACID DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS
#49Amino acid-, peptide- and polypeptide-lipids, isomers, compositions, and uses thereof
#50Branched geminal zwitterionic liquids, method for obtaining same and use thereof as wettability modifiers having viscosity reducing properties
#51Amino acid compositions
#52L-ornithine phenyl acetate and methods of making thereof
#53Polyaspartic acid ester compositions which contain polyaspartic acid esters with primary amino groups and small amounts of fumaric acid dialkyl esters
#54Methods for synthesizing zinc-lysine-chloride complex
#55Methods for synthesizing zinc-lysine-chloride complex
#56PHARMACEUTICALLY ACCEPTABLE SALTS OF FATTY ACIDS
#57Compositions and methods relating to salts of specialized pro-resolving mediators
#58Processes of making L-ornithine phenylacetate
#59Alpha-tea salt forms: compositions and uses for treating disease
#60Glutamine transport inhibitors and methods for treating cancer
#61DNP and DNP prodrug treatment of neuromuscular, neurodegenerative, autoimmune, developmental, traumatic brain injury, concussion, dry eye disease, hearing loss and/or metabolic diseases
#623-(5-chloro-2-oxobenzo[d]oxazol-3(2H)-yl) propanoic acid derivatives as KMO inhibitors
#63COMPOUNDS AND METHODS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES
#64WATER SOLUBLE SALTS OF ALDOSE REDUCTASE INHIBITORS FOR TREATMENT OF DIABETIC COMPLICATIONS
#6518F labeled amino acids, derivatives thereof and method of making same
#66Crystal of amino acid salt of 3-hydroxyisovaleric acid and production method thereof
#67Materials and methods for detection and quantification of β-N-methylamino-L-alanine
#68SUBSTITUTED (1,2,3,4-TETRAHYDROCYCLOPENTA[b]INDOL-3-YL)ACETIC ACID DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS
#69Amino acid-, peptide- and polypeptide-lipids, isomers, compositions, and uses thereof
#70PEPTIDE NUCLEIC ACID (PNA) MONOMERS WITH AN ORTHOGONALLY PROTECTED ESTER MOIETY AND NOVEL INTERMEDIATES AND METHODS RELATED THERETO
#71Ionic liquid and method for dissolving cellulose using the same
#72AROMATIC-CATIONIC PEPTIDES AND USES OF SAME
#73L-ornithine phenyl acetate and methods of making thereof
#74Synergistic compositions
#75DTPA PRODRUGS, COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME
#76Isotopically modified compounds and their use as food supplements
#77FORMS AND COMPOSITIONS OF BIARYL INHIBITORS OF BRUTON'S TYROSINE KINASE
#78Ionic liquid composition and method for dissolving cellulose using the same
#79Enzymatic conjugation of antibodies
#80Processes for the preparation of GalNAc acid derivatives
#81METHOD AND COMPOSITION FOR RETAINING NUTRIENTS IN SOIL AT PLANTING SITES
#82Compounds and methods for the treatment of neurodegenerative diseases
#83Pharmaceutically acceptable salts of fatty acids
#84Compositions and methods relating to salts of specialized pro-resolving mediators
#85Ionic liquid and method for dissolving cellulose using the same
#86Gluconate repressor variant, microorganism containing the same producing L-lysine, and method for producing L-lysine
#87SALTS OF OBETICHOLIC ACID
#88ENZYMATIC CONJUGATION OF POLYPEPTIDES
#89L-ornithine phenyl acetate and methods of making thereof
#90METHOD FOR VISUALIZATION OF CALCIUM CONTAINING COMPONENTS IN BIOLOGICAL SYSTEMS
#91WATER SOLUBLE SALTS OF ALDOSE REDUCTASE INHIBITORS FOR TREATMENT OF DIABETIC COMPLICATIONS
#92Branched geminal zwitterionic liquids, method for obtaining same and use thereof as wettability modifiers having viscosity reducing properties
#93FORMULATIONS FOR THE DELIVERY OF ACTIVE AGENTS TO INSECTS, PLANTS, AND PLANT PATHOGENS
#94Synergistic compositions
#95CRYSTALLINE SALTS OF (Z)-O-OCTADEC-9-EN-1-YL O,O-DIHYDROGEN PHOSPHOROTHIOATE
#96APOE4-TARGETED THERAPUTICS THAT INCREASE SIRT1
#97Salt forms of [R—(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-hepatonic acid
#98Isotopically modified compounds and their use as food supplements
#99Short chain PEGylation of amino acid monomers glutamine, lysine and peptides formed thereby
#100DTPA prodrugs, compositions thereof, and methods of using the same
#101Anaerobic curable compositions containing blocked (meth)acrylate acid compounds
#102Crystallization method and bioavailability
#103Borate-based base generator, and base-reactive composition comprising such base generator
#104Compositions and methods for the treatment of urea cycle disorders and gout
#1053-(5-CHLORO-2-OXOBENZO[D]OXAZOL-3(2H)-YL) PROPANOIC ACID DERIVATIVES AS KMO INHIBITORS
#106HYDRAZINYL LIPIDOIDS AND USES THEREOF
#107Polyester polyquaternary ammonium compound collectors for reverse froth flotation of silicates from nonsulfidic ores
#108ARAMCHOL SALTS
#109Salts
#110N, N, N-trialkyl histidine derivatives useful for the preparation of ergothioneine compounds
#111Alpha-TEA salt forms: compositions and uses for treating disease
#112Salt forms of [R-(R*,R*)]-2-(4-fluorophenyl)-β, δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic-acid
#113Synergistic compositions
#114CRYSTALLIZATION METHOD AND BIOAVAILABILITY
#115Lysine isotopologues, compositions comprising the same and methods of synthesis
#116Substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid derivatives useful in the treatment of autoimmune and inflammatory disorders
#117Crystalline phase of (3S.3S′) 4,4′-disulfanediylbis(3-aminobutane 1-sulfonic acid) with L-lysine
#118Salt forms of [R-(R*,R*)]-2-(4-fluorophenyl)-β, δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-hepatanoic acid
#119L-ornithine phenyl acetate and methods of making thereof
#120Stable isotope-labeled aliphatic amino acid and NMR structural analysis of protein using same
#121METHODS AND COMPOSITIONS FOR MAKING AN AMINO ACID TRIHYDROCHLORIDE
#122Transfection reagents
#123Crystalline salts of (Z)-O-octadec-9-en-1-yl O,O-dihydrogen phosphorothioate
#124Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents
#125Pharmaceutically acceptable salts of fatty acids
#126Amino acid-modified siloxanes, process for preparing them and application
#127Enzymatic conjugation of antibodies
#128Salt forms of [R-(R*,R*)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid
#129Process for the purification of polyaminocarboxylates
#130Covalently functionalized nanodiamond-based MALDI matrices and methods of use thereof
#131LIPIDS FOR THE DELIVERY OF ACTIVE AGENTS
#132AROMATIC-CATIONIC PEPTIDES AND USES OF SAME
#133L-ornithine phenyl acetate and methods of making thereof
#134Nitric oxide donor compounds
#135Aspartic resins
#136Process for producing granules comprising one or more complexing agent salts
#137COMPOSITION AND METHOD OF SYNTHESIZING A BIOMOLECULE AND ITS THERAPEUTICS APPLICATIONS
#138NOVEL COMPOUND AND MEDICAL USE THEREOF
#139Amine-containing lipidoids and uses thereof
#140NOVEL POLYMORPHS AND SALTS
#141Amine salts of laquinimod
#142Composition and method for reducing hydrate agglomeration
#143Substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid derivatives useful in the treatment of autoimmune and inflammatory disorders
#144Solid forms of curcumin
#145Crystalline forms of (R)-3-[N-(3'-chlorobiphenyl-4-ylmethyl)-N'-(3-hydroxyisoxazole-5-carbonyl)hydrazino]-2-hydroxyproprionic acid isopropyl ester
#146Salt of a pyrimidin derivative
#147Enzymatic conjugation of polypeptides
#148Process for Preparing Crystalline 3,6,9-triaza-3,6,9-tris(carboxymethyl)-4-(4-ethoxybenzyl)undecanedioic Acid and Use for Production of Primovist®
#149Amino acid-, peptide-and polypeptide-lipids, isomers, compositions, and uses thereof
#150AMINO ACID GROUP-MODIFIED ORGANOPOLYSILOXANE AND SILANE, AMINO ACID GROUP-CONTAINING COMPOUND, AND PRODUCTION METHOD THEREOF
#151Amino acid group-modified organopolysiloxane and silane, amino acid group-containing compound, and production method thereof
#152NOVEL COMPOUNDS WITH HIGH THERAPEUTIC INDEX
#153Salt forms of [R-(R*,R*)]-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid
#154Transfection reagents
#155Paramagnetic polynuclear metal complex having high self-relaxation rate, preparation method thereof, and contrast medium containing same
#156L-ornithine phenyl acetate and methods of making thereof
#157Composition and method for reducing hydrate agglomeration
#158Amine-Containing Transfection Reagents and methods for making and using same
#159Co-precipitated salts of fatty acids
#160Nicotianamine-derived metallophore and processes for producing same
#161Process for producing granules comprising one or more complexing agent salts
#162Complexes of 4-hydroperoxy ifosfamide as anti-tumor agents
#163Amino acid compositions
#164SHIP 1 MODULATOR COMPOUNDS
#165Polymorphs and salts
#166Co-precipitated salts of fatty acids
#167NITRIC OXIDE RELEASING AMINO ACID ESTER COMPOUND, COMPOSITION AND METHOD OF USE
#168Salt forms of [R-(R*,R*)]-2-(4-fluorophenyl)-beta, alpha-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid
#169Derivative compounds of N-6-Trimethy-L-Lysine for therapeutic use
#170Method of synthesis and purification of N-6-trimethyl-L-lysine and derivative compounds
#171Method of treating a human being for a class of metabolic defects and energy production disorders
#172Method of treating a human being for a class of neurological defects and seizure disorders
#173Amino acid group-modified organopolysiloxane and silane, amino acid group-containing compound, and production method thereof
#174Substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid derivatives useful in the treatment of autoimmune and inflammatory disorders
#175Therapies for cancer using isotopically substituted lysine
#176SHIP 1 MODULATOR PRODRUGS
#177COMPOUND INDUCING ANGIOGENESIS RESPONSE IN ISCHAEMIC TISSUES
#178L-ornithine phenyl acetate and methods of making thereof
#179USE OF AT LEAST ONE LYSINE-DERIVED COMPOUND FOR THE CONDITIONING OF KERATINOUS FIBERS, COSMETIC COMPOSITION COMPRISING IT AND METHOD FOR CONDITIONING THE FIBERS
#180Isotopically modified compounds and their use as food supplements
#181Transfection reagents
#182Non-Natural Amino Acids and Neurotensin Analogues Thereof
#183Eflornithine Prodrugs, Conjugates and Salts, and Methods of Use Thereof
#184Amino acid salts of prostaglandins
#185Amino acid salts of prostaglandins
#186NITRIC OXIDE DONOR COMPOUNDS
#187Method and composition for postoperative wound healing
#188L-THREONINE DERIVATIVES OF HIGH THERAPEUTIC INDEX
#189L-threonine derivatives of high therapeutic index
#190Preservative compositions
#191L-Threonine derivatives of high therapeutic index
#192Method for producing amino acid phosphates
#193N-Methylation of amino acids
#194Stable active compound complex of salts of o-acetylsalicylic acid with basic amino acids and glycine
#195N-N-Acyloxypropyl Lysine Methyl Ester-and N,N-Bis(N-Acyloxypropyl) Lysine Methyl Ester-Type Compounds and Use Thereof as Surface-Active Agents with an Antimicrobial Activity
#196SYNTHETIC NON-FOULING AMINO ACIDS
#197Compounds for modulating the glycolysis enzyme complex and/or the transaminase complex
#198Transfection reagents
#199GLYCEROL ESTER DERIVATIVE HAVING METAL CHELATE STRUCTURE
#200Crystals of L-ornithine and process for producing the same
#201Stable isotope-labeled aliphatic amino acids, method for incorporating the same in target protein and method for NMR-structural analysis of proteins
#202Method for recovering a basic amino acid from a fermentation liquor
#203Methods for purifying amino acids
#204Salt forms of [R—(R*,R*)]-2-(4-fluorophenyl)-β, δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid
#205Anti-inflammatory inhalation pharmaceutical composition
#206Preparation of amino acid-fatty acid anhydrides
#207Salts of isophosphoramide mustard and analogs thereof as anti-tumor Agents
#208METHOD FOR PRODUCING OPTICALLY ACTIVE (4E)-5-CHLORO-2-ISOPROPYL-4-PENTENOIC ACID OR BASIC AMINO ACID SALT THEREOF
#209Novel Salts of Fumaric Acid Monoalkylesters and Their Pharmaceutical Use
#210Methods for synthesis of carotenoids, including analogs, derivatives, and synthetic and biological intermediates
#211Cosmetic Composition Comprising at Least One Fatty-Chain Polylysine, Which is Intended to Improve the Surface State of Keratin Fibers
#212Preparation of amino acid-fatty acid anhydrides
#213Zinc complexes of natural amino acids for treating elevated copper caused toxicities
#214Method For Recovering a Basic Amino Acid Form a Fermentation Liquor ll
#215Salt forms of [R-(R*,R*)]-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid
#216Methods for making intermediates and oxytocin analogues
#217Salt forms of [R-(R*,R*)]-2-(4-fluorophenyl)-β, δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)Carbonyl]-1H-pyrrole-1-heptanoic acid
#218Anti-inflamatory inhalation pharmaceutical composition
#219Crystal of L-Ornithine-Citric Acid Salt
#220Transfection reagents
#221Transfection reagents
#222Aztreonam L-lysine and methods for the preparation and analysis thereof
#223L-Threonine derivatives of high therapeutic index
#224Method of making a diL-lysine monosulfate trihydrate crystal
#225Mono-lysine salts of azole compounds
#226Substituted amino acids as erythropoietin mimetics
#227Methods for making intermediates and oxytocin analogues
#228Compounds with high therapeutic index
#229Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents
#230Therapeutic compositions and uses
#231Method for producing lysine derivative
#232Transfection reagents
#233Stable salts of o-acetylsalicylic acid containing basic amino acids II
#234Transfection reagents
#235New transfection reagents
#236Transfection reagents
#237Process for producing optically active amino acid derivatives
#238DiL-lysine monosulfate trihydrate crystal and method of making
#239Transfection reagents
#240Stable isotope-labeled amino acid and method for incorporating same into target protein
#241Aztreonam L-lysine and methods for the preparation thereof
#242Stable salts of O-acetylsalicylic acid with basic amino acids
#243Amino acid compositions
#244Amino acid compositions
#245Amino acid compositions
#246Amino acid supplement formulations
#247Amino acid compositions